An official warning about newer antipsychotics in demented elderly people appears to have deterred some doctors from prescribing the drugs, a new U.S. study shows. The so-called black box warning was issued by the Food and Drug Administration in 2005 after studies found elderly people on newer antipsychotics such as Janssen’s Risperdal and AstraZeneca’s Seroquel [...]
Continue reading...Friday, May 15, 2009
TUESDAY, May 12 (HealthDay News) — Checking levels of certain biomarkers in cerebrospinal fluid may help predict the rate of cognitive decline in people with very mild dementia, and this information could be used to improve the effectiveness of clinical trials, say U.S. researchers. Their study, published in the May issue of the journal Archives [...]
Continue reading...
Wednesday, February 9, 2011
0 Comments